Kodak created a separate business unit in February to supportthe sale of cardiac imaging products. Joseph Barry, a 23-yearKodak veteran, was named general manager of the cardiology businessunit, a part of Kodak's Health Sciences division. The dominant
Kodak created a separate business unit in February to supportthe sale of cardiac imaging products. Joseph Barry, a 23-yearKodak veteran, was named general manager of the cardiology businessunit, a part of Kodak's Health Sciences division.
The dominant medical film vendor anticipates continued stronggrowth in cardiac catheterization procedures and demand for relatedimaging products. Formation of a separate business unit was anotherstep in Kodak's long-term strategy to build this business, Barrytold SCAN.
Kodak purchased a cine-radiography film processor line withits acquisition of Jamieson Film last year (SCAN 8/1/90). TheRochester, NY, company now sells cardiac cath film, processingchemicals, processors and other accessory products. Vari-X ofIrvine, CA, is Kodak's largest competitor in the cardiac cathfilm market, Barry said.
The new business unit is responsible for Kodak's worldwidecardiac imaging business. A team of technical specialists is beingbuilt to support the work of dealers and Kodak's x-ray film salesrepresentatives, he said.
Cardiac sales require a distinct marketing and sales effort,however. Fewer than 5% of cardiology labs are part of hospitalx-ray departments, Barry said.
The number of cath labs is growing about 10% to 15% a year.While some of that growth involves digital imaging equipment,cardiac cath procedures continue to rely mainly on film.
BRIEFLY NOTED:
MICA is reorganizing with the intent of improving coordinationof the firm's imaging center and shared-service businesses. NathanKaufman, president of MICA's center operating group, resignedin March (SCAN 4/10/91).
Patitucci, a former GE Medical executive, is leaving Discoveryfor personal reasons. He may continue as a consultant to the company.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.